Aurobindo Pharma Limited — Others, 26-06-2025: Trading Window

Aurobindo Pharma has announced a board meeting for declaring the financial results for the quarter and half-year ending June 30, 2025. The trading window for all designated persons, including promoters, directors, key managers, employees, and their immediate relatives, will be closed from July 1, 2025, until 48 hours after the results are announced. This move ensures compliance with internal policies to prevent insider trading during sensitive periods.